Pepsi = BI is just part of the Dana Farber/Harvard Cancer Center. They are supposed to share exact same protocol as the primary DF building. Basically, BI is just the DFCancerInstitute - DFCI. The DFCI occupies what we used to think of as a few free-standing hospital entities. A single trial can take place at 2 or even 3 separate locations and still be considered as just taking place at DFCI. It makes a LOT of work for the Drug dvlpmnt research team and IRB - making sure everyone is following identical protocol - but it allows for more research to be done. Anyway - when BI gets involved, the might just continue saying the trial is at Dana Farber CI- because technically that would be true.

http://www.dfhcc.harvard.edu/home/